Register entry
- Registered sites
- 1
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 1
- Base
- United States
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| CellTrans Inc. | 1740 W. Taylor St, Ste C200, Chicago, Illinois (IL) 60612, United States (USA) | Active ingredient (API) manufacture | 3019202665117774787 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| LANTIDRA | DONISLECEL | solution, intravascular | 73539-001BLA |
Neighbours
Registered in the same town
6- Ecolab Inc.Chicago, IL
- Bajaj Healthcare LtdChicago, IL
- Kashiv BioSciences, LLCChicago, IL
- AltaThera Pharmaceuticals LLCChicago, IL
- Korex Chicago LLCChicago, IL
- Primrose Candy CompanyChicago, IL
Compare
Comparable companies in United States
- OHM PHARMA INC.1 site · 155 NDC
- Liddell Laboratories, Inc.1 site · 48 NDC
- Piramal Critical Care Inc1 site · 41 NDC
- Pharma Nobis LLC1 site · 40 NDC
- Chattem Chemicals, Inc.1 site · 35 NDC
- Reliable Biopharmaceutical, LLC1 site · 33 NDC
- King Bio Inc1 site · 30 NDC
- Catalent Indiana, LLC1 site · 27 NDC
- Sigmapharm Laboratories, LLC1 site · 27 NDC
- Exela Pharma Sciences1 site · 25 NDC
Enquiry
Common questions
- Is CellTrans Inc. FDA approved?
- CellTrans Inc. holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are CellTrans Inc.'s drugs manufactured?
- The FDA register lists Chicago, IL. Registered operations: active ingredient (API) manufacture.
- What drugs does CellTrans Inc. make?
- 1 product is listed under CellTrans Inc. in the openFDA NDC Directory, most often as solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.